Alistair M Cook
Alistair M Cook
Research Fellow, School of Biological Sciences, University of Western Australia
Verified email at - Homepage
Cited by
Cited by
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
AK Nowak, WJ Lesterhuis, PS Kok, C Brown, BGM Hughes, DJ Karikios, ...
The Lancet Oncology 21 (9), 1213-1223, 2020
Chemotherapy and immunotherapy: mapping the road ahead
AM Cook, WJ Lesterhuis, AK Nowak, RA Lake
Current opinion in immunology 39, 23-29, 2016
Identification of a bipotent epithelial progenitor population in the adult thymus
S Ulyanchenko, KE O’Neill, T Medley, AM Farley, HJ Vaidya, AM Cook, ...
Cell reports 14 (12), 2819-2832, 2016
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
AK Nowak, AM Cook, AM McDonnell, MJ Millward, J Creaney, RJ Francis, ...
Annals of Oncology 26 (12), 2483-2490, 2015
Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies
AM Cook, AM McDonnell, RA Lake, AK Nowak
Oncoimmunology 5 (3), e1066062, 2016
Enhancing the efficacy of immunotherapy using radiotherapy
S Keam, S Gill, MA Ebert, AK Nowak, AM Cook
Clinical & Translational Immunology 9 (9), e1169, 2020
Antiangiogeneic strategies in mesothelioma
AK Nowak, S Brosseau, A Cook, G Zalcman
Frontiers in oncology 10, 126, 2020
Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment
WJ Aston, DE Hope, AM Cook, L Boon, I Dick, AK Nowak, RA Lake, ...
Oncoimmunology 8 (11), e1641390, 2019
Immune checkpoint inhibition for the treatment of mesothelioma
AK Nowak, A McDonnell, A Cook
Expert Opinion on Biological Therapy 19 (7), 697-706, 2019
Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors
SJ Dart, AM Cook, MJ Millward, AM McDonnell, WL Chin, MU Hakeem, ...
Scientific Reports 11 (1), 15312, 2021
Older patients are immunocompromised by cytokine depletion and loss of innate immune function after HIP fracture surgery
AG Sutherland, A Cook, C Miller, L Duncan, R Yuecel, SD Heys, ...
Geriatric orthopaedic surgery & rehabilitation 6 (4), 295-302, 2015
In vivo noninvasive preclinical tumor hypoxia imaging methods: a review
RA D’Alonzo, S Gill, P Rowshanfarzad, S Keam, KM MacKinnon, ...
International Journal of Radiation Biology 97 (5), 593-631, 2021
Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
J Chee, MW Watson, A Chopra, B Nguyen, AM Cook, J Creaney, ...
BMC research notes 11, 1-6, 2018
Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell …
AM McDonnell, A Cook, BWS Robinson, RA Lake, AK Nowak
BMC cancer 17, 1-15, 2017
Immune checkpoint inhibitor therapy for malignant pleural mesothelioma
AK Nowak, WL Chin, S Keam, A Cook
Lung Cancer 162, 162-168, 2021
Proliferation and lineage potential in fetal thymic epithelial progenitor cells
AM Cook
The University of Edinburgh, 2010
Effects of Photon Radiation on DNA Damage, Cell Proliferation, Cell Survival, and Apoptosis of Murine and Human Mesothelioma Cell Lines
S Keam, KM MacKinnon, RA D'Alonzo, S Gill, MA Ebert, AK Nowak, ...
Advances in Radiation Oncology 7 (6), 101013, 2022
The future of mesothelioma research: basic science research
VS Fear, AM Cook, SA Fisher
Caring for Patients with Mesothelioma: Principles and Guidelines, 203-227, 2019
A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers
AM Cook, A McDonnell, MJ Millward, J Creaney, A Hasani, M McMullen, ...
Expert Review of Anticancer Therapy 21 (5), 465-474, 2021
Immune marker expression of irradiated mesothelioma cell lines
F Chang, S Keam, TS Hoang, J Creaney, S Gill, AK Nowak, M Ebert, ...
Frontiers in Oncology 12, 1020493, 2022
The system can't perform the operation now. Try again later.
Articles 1–20